Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Osteoporosis
Published in: Archives of Osteoporosis 1/2021

01-12-2021 | Osteoporosis | Original Article

Prevalence of osteoporosis among the elderly population of Iran

Authors: Noushin Fahimfar, Sima Noorali, Shakiba Yousefi, Safoora Gharibzadeh, Gita Shafiee, Nekoo Panahi, Mahnaz Sanjari, Ramin Heshmat, Farshad Sharifi, Neda Mehrdad, Alireza Raeisi, Iraj Nabipour, Bagher Larijani, Afshin Ostovar

Published in: Archives of Osteoporosis | Issue 1/2021

Login to get access

Abstract

Summary

In a large population-based study of Iran, the age-standardized prevalence of osteoporosis was 24.6% in men and 62.7% in women aged ≥ 60 years. Osteoporosis was negatively associated with body mass index in both sexes, and with diabetes in men and hypertriglyceridemia in women.

Purpose

Population aging has made osteoporosis and osteoporotic fractures an important health problem, especially in developing countries. This study aimed to explore the prevalence of osteoporosis and associated factors among the elderly population of the south-west of Iran.

Methods

Baseline data of the second stage of the Bushehr Elderly Health program was used. Spinal, total hip, or femoral neck osteoporosis was described as a BMD that lies 2.5 standard deviations or more, below the average values of a young healthy adult in the lumbar spine, total hip, or femoral neck, respectively. Osteoporosis at either site was defined as total osteoporosis. Age-standardized prevalence of osteoporosis was estimated. We used the modified Poisson regression with a robust variance estimator to identify the factors related to osteoporosis, adjusting for potential confounders.

Results

Overall, 2425 individuals (1166 men) aged over 60 years were included. In all, total osteoporosis was detected in 1006 (41.5%) of the participants. Using the reference value derived from Caucasian women aged 20–29 years, the age-standardized prevalence of total osteoporosis was 24.6 (95% CI: 21.9–27.3) in men, and 62.7 (95% CI: 60.0–65.4) in women. In men, osteoporosis was positively associated with age, smoking, history of fracture, and history of renal/liver diseases and negatively associated with body mass index (BMI) and diabetes. BMI, hypertriglyceridemia, and education were negatively correlated with osteoporosis in women, while years after menopause and history of fracture increased the likelihood of osteoporosis, significantly.

Conclusion

Results support the high prevalence of osteoporosis and osteopenia in the elderly population. Considering the importance of severe complications, especially fractures, comprehensive interventions should be expanded.
Literature
1.
Leslie WD, Morin SN (2014) Osteoporosis epidemiology 2013: implications for diagnosis, risk assessment, and treatment. Curr Opin Rheumatol 26(4):440–446PubMedCrossRef
2.
Cooper C, Campion G (1992) and L.r. Melton, Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2(6):285–289PubMedCrossRef
3.
Cosman F, de Beur SJ, LeBoff M, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis Foundation (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381PubMedPubMedCentralCrossRef
4.
5.
Handa R, Kalla AA, Maalouf G (2008) Osteoporosis in developing countries. Best Pract Res Clin Rheumatol 22(4):693–708PubMedCrossRef
6.
7.
Oden A et al (2015) Burden of high fracture probability worldwide: secular increases 2010–2040. Osteoporos Int 26(9):2243–2248PubMedCrossRef
8.
Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194(2):S3–S11PubMedCrossRef
9.
El-Hajj Fuleihan G, Adib G, Nauroy L (2011) The middle east & Africa regional audit, epidemiology, costs & burden of osteoporosis in 2011. Int Osteoporos Found 102011–105000
10.
Pourhashem Z et al (2012) Prevalence of osteoporosis and its association with serum vitamin D level in older people in Amirkola, North of Iran. Caspian J Intern Med 3(1):347PubMedPubMedCentral
11.
Doosti-Irani A, Ghafari M, Cheraghi Z (2018) The high prevalence of osteoporosis as a preventable disease: the need for greater attention to prevention programs in Iran. Iran J Public Health 47(8):1220–1221PubMedPubMedCentral
12.
Jordan K, Cooper C (2002) Epidemiology of osteoporosis. Best practice & research. Clin Rheumatol 16(5):795–806
13.
Rahnavard Z et al (2009) The incidence of osteoporotic hip fracture: Iranian Multicenter osteoporosis study (IMOS). Res J Biol Sci 4(2):171–173
14.
Ostovar A, Nabipour I, Larijani B, Heshmat R, Darabi H, Vahdat K, Ravanipour M, Mehrdad N, Raeisi A, Heidari G, Shafiee G, Haeri M, Pourbehi M, Sharifi F, Noroozi A, Tahmasebi R, Aghaei Meybodi H, Assadi M, Farrokhi S, Nemati R, Amini MR, Barekat M, Amini A, Salimipour H, Dobaradaran S, Moshtaghi D (2015) Bushehr elderly health (BEH) Programme, phase I (cardiovascular system). BMJ Open 5(12):e009597PubMedPubMedCentralCrossRef
15.
Shafiee G, Ostovar A, Heshmat R, Darabi H, Sharifi F, Raeisi A, Mehrdad N, Shadman Z, Razi F, Amini MR, Arzaghi SM, Meybodi HA, Soltani A, Nabipour I, Larijani B (2017) Bushehr Elderly Health (BEH) programme: study protocol and design of musculoskeletal system and cognitive function (stage II). BMJ Open 7(8):e013606PubMedPubMedCentralCrossRef
16.
Kanis JA et al (2013) Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporos Int 24(11):2763–2764PubMedPubMedCentralCrossRef
17.
Brooks GA, Butte NF, Rand WM, Flatt JP, Caballero B (2004) Chronicle of the Institute of Medicine physical activity recommendation: how a physical activity recommendation came to be among dietary recommendations. Am J Clin Nutr 79(5):921S–930SPubMedCrossRef
18.
Mahan LK, Raymond JL (2016) Krause’s food & the nutrition care process-e-book. Elsevier Health Sci
19.
20.
Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159(7):702–706PubMedCrossRef
21.
Wade S et al (2014) Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos 9(1):182PubMedCrossRef
22.
Gheita TA, Hammam N (2018) Epidemiology and awareness of osteoporosis: a viewpoint from the Middle East and North Africa. Int J Clin Rheumatol 134
23.
Vijayakumar R, Büsselberg D (2016) Osteoporosis: an under-recognized public health problem: local and global risk factors and its regional and worldwide prevalence. J Local Global Health Sci 2
24.
Ho SC, Chen Y-m, Woo JL (2005) Educational level and osteoporosis risk in postmenopausal Chinese women. Am J Epidemiol 161(7):680–690PubMedCrossRef
25.
Keramat A, Patwardhan B, Larijani B, Chopra A, Mithal A, Chakravarty D, Adibi H, Khosravi A (2008) The assessment of osteoporosis risk factors in Iranian women compared with Indian women. BMC Musculoskelet Disord 9(1):28PubMedPubMedCentralCrossRef
26.
27.
Mishra AK, Gajjar K, Patel K (2016) Association between body mass index and bone mineral density among healthy women in India. Int J Med Res Health Sci 5(4):156–160
28.
Saito M, Kida Y, Kato S, Marumo K (2014) Diabetes, collagen, and bone quality. Curr Osteoporos Rep 12(2):181–188PubMedCrossRef
29.
Tell-Lebanon O, Rotman-Pikielny P (2016) Osteoporosis and diabetes - in which way are they related? Harefuah 155(11):697–701PubMed
30.
Ho-Pham LT, Chau PMN, Do AT, Nguyen HC, Nguyen TV (2018) Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study. Osteoporos Int 29(9):2059–2067PubMedCrossRef
31.
32.
Demir B, Haberal A, Geyik P, Baskan B, Ozturkoglu E, Karacay O, Deveci S (2008) Identification of the risk factors for osteoporosis among postmenopausal women. Maturitas 60(3-4):253–256PubMedCrossRef
33.
34.
Turan V (2011) Grand-grand multiparity (more than 10 deliveries) does not convey a risk for osteoporosis. Acta Obstet Gynecol Scand 90(12):1440–1442PubMedCrossRef
35.
Allali F, Maaroufi H, Aichaoui SE, Khazani H, Saoud B, Benyahya B, Abouqal R, Hajjaj-Hassouni N (2007) Influence of parity on bone mineral density and peripheral fracture risk in Moroccan postmenopausal women. Maturitas 57(4):392–398PubMedCrossRef
36.
Wong SK et al (2016) The relationship between metabolic syndrome and osteoporosis: a review. Nutrients 8(6)
37.
Adami S, Braga V, Zamboni M, Gatti D, Rossini M, Bakri J, Battaglia E (2004) Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int 74(2):136–142PubMedCrossRef
38.
Panahi N, Soltani A, Ghasem-Zadeh A, Shafiee G, Heshmat R, Razi F, Mehrdad N, Nabipour I, Larijani B, Ostovar A (2019) Associations between the lipid profile and the lumbar spine bone mineral density and trabecular bone score in elderly Iranian individuals participating in the Bushehr Elderly Health Program: a population-based study. Arch Osteoporos 14(1):52PubMedCrossRef
39.
Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, Chihara K (2002) Plasma lipids and osteoporosis in postmenopausal women. Endocr J 49(2):211–217PubMedCrossRef
40.
Chen YY, Wang WW, Yang L, Chen WW, Zhang HX (2018) Association between lipid profiles and osteoporosis in postmenopausal women: a meta-analysis. Eur Rev Med Pharmacol Sci 22(1):1–9PubMed
41.
Anaforoglu I, Nar-Demirer A, Bascil-Tutuncu N, Ertorer ME (2009) Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes. J Diabetes Complicat 23(1):12–17CrossRef
42.
43.
Sassi F et al (2018) Type 2 diabetes affects bone cells precursors and bone turnover. BMC Endocr Disord 18(1):1–8CrossRef
44.
Hu Z, Ma C, Liang Y, Zou S, Liu X (2019) Osteoclasts in bone regeneration under type 2 diabetes mellitus. Acta Biomater 84:402–413PubMedCrossRef
45.
Ebrahimpur M, Sharifi F, Nezhad FA, Bagherzadeh M, Ostovar A, Shafiee G, Heshmat R, Mehrdad N, Razi F, Khashayar P, Nabipour I, Larijani B (2019) Effect of diabetes on BMD and TBS values as determinants of bone health in the elderly: Bushehr Elderly Health program. J Diab Metab Disord 18(1):99–106CrossRef
46.
Yang S, Nguyen ND, Center JR, Eisman JA, Nguyen TV (2014) Association between hypertension and fragility fracture: a longitudinal study. Osteoporos Int 25(1):97–103PubMedCrossRef
47.
Zhang J, Zhang K, Shi H, Tang Z (2015) A cross-sectional study to evaluate the associations between hypertension and osteoporosis in Chinese postmenopausal women. Int J Clin Exp Med 8(11):21194–21200PubMedPubMedCentral
48.
Silva TR, Franz R, Maturana MA, Spritzer PM (2015) Associations between body composition and lifestyle factors with bone mineral density according to time since menopause in women from Southern Brazil: a cross-sectional study. BMC Endocr Disord 15:71PubMedPubMedCentralCrossRef
49.
Oura P, Paananen M, Niinimäki J, Tammelin T, Auvinen J, Korpelainen R, Karppinen J, Junno JA (2017) High-impact exercise in adulthood and vertebral dimensions in midlife - the Northern Finland Birth Cohort 1966 study. BMC Musculoskelet Disord 18(1):433PubMedPubMedCentralCrossRef
50.
Dallanezi G, Freire B, Nahás E, Nahás-Neto J, Corrente J, Mazeto G (2016) Physical activity level of post-menopausal women with low bone mineral density. Rev Bras Ginecol Obstet 38(5):225–230PubMedCrossRef
51.
Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, Humphrey MB, Lane NE, Magrey M, Miller M, Morrison L, Rao M, Byun Robinson A, Saha S, Wolver S, Bannuru RR, Vaysbrot E, Osani M, Turgunbaev M, Miller AS, McAlindon T (2017) 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Care Res 69(8):1095–1110CrossRef
52.
Rizzoli R, Biver E (2015) Glucocorticoid-induced osteoporosis: who to treat with what agent? Nat Rev Rheumatol 11(2):98–109PubMedCrossRef
53.
Ma CC, Xu SQ, Gong X, Wu Y, Qi S, Liu W, Xu JH (2017) Prevalence and risk factors associated with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis. Arch Osteoporos 12(1):33PubMedCrossRef
54.
Baranova IA, Ershova OB, Anaev EK, Anokhina TN, Anoshenkova ОN, Batyn SZ, Belyaeva EA, Bolshakova TY, Volkorezov IA, Eliseeva LN, Kashnazarova EV, Kinyaikin MF, Kirpikova MN, Klyuchnikova EP, Korolev MA, Kuneevskaya IV, Masneva LV, Muradyants AA, Otteva EN, Petrachkova TN, Peshekhonova LK, Povzun AS, Raskina TA, Smirnova ML, Toroptsova NV, Khasanova RB, Shamsutdinova NG, Shaporova NL, Shitova NS, Shkireeva SY, Shostak NA, Lesnyak OM (2015) Analysis of the state-of-the-art of consulting medical care to patients with glucocorticoid-induced osteoporosis or its risk according to the data of a questionnaire survey (GLUCOST study). Ter Arkh 87(5):58–64PubMedCrossRef
55.
Tabrizi R, Moosazadeh M, Akbari M, Dabbaghmanesh MH, Mohamadkhani M, Asemi Z, Heydari ST, Akbari M, Lankarani KB (2018) High prevalence of vitamin D deficiency among Iranian population: a systematic review and meta-analysis. Iran J Med Sci 43(2):125–139PubMedPubMedCentral
56.
Heshmat R et al (2008) Vitamin D deficiency in Iran: a multi-center study among different urban areas. Iran J Public Health 37(1):72–78
Metadata
Title
Prevalence of osteoporosis among the elderly population of Iran
Authors
Noushin Fahimfar
Sima Noorali
Shakiba Yousefi
Safoora Gharibzadeh
Gita Shafiee
Nekoo Panahi
Mahnaz Sanjari
Ramin Heshmat
Farshad Sharifi
Neda Mehrdad
Alireza Raeisi
Iraj Nabipour
Bagher Larijani
Afshin Ostovar
Publication date
01-12-2021
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1/2021
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-020-00872-8

Other articles of this Issue 1/2021

Archives of Osteoporosis 1/2021 Go to the issue

Original Article

Biochemical characteristics and calcium and PTH levels of patients with high normal and elevated serum 25(OH)D levels in Turkey: DeVIT-TOX survey

Letter to the Editor

Position statement of the Latin American Federation of Endocrinology on osteoporosis

Original Article

A long-term trajectory of bone mineral density in childhood cancer survivors after discontinuation of treatment: retrospective cohort study

Original Article

The serum 25(OH)D level and hand grip strength for fall risk assessment among osteoporotic elderly Japanese women

Original Article

Long-term trabecular bone score and bone mineral density changes in Chinese antiretroviral-treated HIV-infected individuals

Original Article

Factors associated with delayed surgery in elderly hip fractures in India